Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Choosing the best Dividend Aristocrats Etf for retirees involves yield, cost, and risk assessment. This intro guides the evaluation process.
22,555 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
IP Strategy said its board approved a buyback of up to 1,000,000 common shares through Dec. 31, 2026, potentially tri...
Starting early with a modest monthly save can outpace a later, bigger contribution plan. The idea behind '$400 month ...
Metallus faces a dynamic metals market in 2025. This guide breaks down expected MTUS 2025 earnings, the drivers behin...
A private phone call reportedly sparked a rift in Holly Ramsay Adam Peaty’s family circle, underscoring how personal ...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
XRP traders are watching a ripple price alert: last signal that historically preceded a major rally. Analysts caution...
Ethereum hovers around $1,800 as thin volume and mixed social signals keep the market gridlocked. A tweet-driven mome...
A Sunrun director recently disposed of a large block of shares. This article breaks down insider sales, what they imp...
SpaceX, Rocket Lab, and AST SpaceMobile retreat as a China rocket milestone and an oil price spike pressure space-sto...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...